Schlesinger Michael A. 4

4 · Ortho Clinical Diagnostics Holdings plc · Filed Aug 13, 2021

Form 4

Period: 2021-08-11

EVP, GC and Secretary

Transactions

Sale
Ordinary Shares, $0.00001 par value
2021-08-11$19.76/sh−72,585$1,434,621→ 87,637 total
Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-12$6.28/sh+8,100$50,868→ 95,737 total
Sale
Ordinary Shares, $0.00001 par value
2021-08-12$20.00/sh−8,100$162,003→ 87,637 total
Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-13$6.28/sh+4,300$27,004→ 91,937 total
Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-11$6.28/sh+72,585$455,834→ 160,222 total
Sale
Ordinary Shares, $0.00001 par value
2021-08-13$20.00/sh−4,300$86,003→ 87,637 total
Exercise/Conversion
Stock Option
2021-08-11−72,585→ 350,922 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (72,585 underlying)
Exercise/Conversion
Stock Option
2021-08-12−8,100→ 342,822 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (8,100 underlying)
Exercise/Conversion
Stock Option
2021-08-13−4,300→ 338,522 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (4,300 underlying)

Footnotes (6)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
[F3]Represents the weighted average sales price for the price increments ranging from $19.4800 to $20.0700.
[F4]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0050.
[F5]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0100.
[F6]The stock option is fully vested and exercisable.

Documents

1 file